B

Bristol-Myers Squibb

Bristol-Myers Squibb settled claims of overcharging for HIV cART drugs. The deadline to file a claim has passed.

ClosedCalifornia onlyClaim status: Closed on October 28, 2022Payout: VariesNo longer claimable

About this settlement

Allegations of antitrust violations and price overcharging for specific HIV medications.

Bristol-Myers Squibb and other drug manufacturers faced allegations of conspiring to overcharge for HIV cART drugs. A $10.8 million settlement was reached. The claim filing deadline has passed.

Who qualifies

  • Individuals or entities who purchased Atripla, Complera, Evotaz, Reyataz, Sustiva, Stribild, Truvada, or their generic equivalents directly from manufacturers.
  • Purchases made between October 6, 2016, and October 19, 2021.

Varies

Claim status: Closed on October 28, 2022

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

93 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

743 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon